S. 2315 · 115th Congress
Over-the-Counter Drug Safety, Innovation, and Reform Act
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 115th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
R
IsaksonSponsor3 cosponsors · 2 D, 1 R
1 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
This bill amends the Federal Food, Drug, and Cosmetic Act to substantially revise how over-the-counter (OTC)drugs are approved.
What it does: CRS summary · Introduced in Senate · Jan 17, 2018
Over-the-Counter Drug Safety, Innovation, and Reform Act
This bill amends the Federal Food, Drug, and Cosmetic Act to substantially revise how over-the-counter (OTC)drugs are approved.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Over-the-Counter Drug Safety, Innovation, and Reform Act
Latest action (May 14, 2018): Placed on Senate Legislative Calendar under General Orders. Calendar No. 413.
Policy area: Health · Origin: Senate · Introduced: Jan 17, 2018
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.